$740 Million is the total value of SABBY MANAGEMENT, LLC's 184 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 42.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
COCP | Sell | COCRYSTAL PHARMA INC | $5,424,000 | -29.0% | 5,165,416 | -15.5% | 0.73% | -31.9% |
Sell | ATOSSA THERAPEUTICS INCput | $5,126,000 | -68.1% | 15,725 | -38.2% | 0.69% | -69.4% | |
VINC | Sell | VINCERX PHARMA INC | $3,234,000 | -8.2% | 200,000 | -26.2% | 0.44% | -11.9% |
Sell | KEMPHARM INCput | $2,717,000 | -70.2% | 2,912 | -59.1% | 0.37% | -71.5% | |
Sell | MOGO INCput | $2,379,000 | -63.0% | 5,506 | -32.7% | 0.32% | -64.5% | |
Sell | ORAMED PHARMACEUTICALS INCput | $2,136,000 | +12.6% | 972 | -31.5% | 0.29% | +8.2% | |
AUTL | Sell | AUTOLUS THERAPEUTICS LTDads | $1,965,000 | -26.0% | 300,000 | -25.0% | 0.27% | -28.9% |
MOGO | Sell | MOGO INC | $1,780,000 | -50.7% | 412,059 | -10.5% | 0.24% | -52.7% |
PCVX | Sell | VAXCYTE INC | $1,687,000 | -36.5% | 66,483 | -43.7% | 0.23% | -39.0% |
GLBS | Sell | GLOBUS MARITIME LTD | $1,626,000 | -40.2% | 556,883 | -20.5% | 0.22% | -42.6% |
WIMI | Sell | WIMI HOLOGRAM CLOUD INCads | $1,581,000 | -54.0% | 383,791 | -38.7% | 0.21% | -55.9% |
Sell | SPI ENERGY CO LTDput | $1,571,000 | -96.1% | 3,130 | -15.7% | 0.21% | -96.3% | |
Sell | DIGITAL ALLY INCput | $1,561,000 | -47.8% | 12,899 | -22.4% | 0.21% | -50.0% | |
KRBP | Sell | KIROMIC BIOPHARMA INC | $1,468,000 | -39.0% | 478,122 | -4.5% | 0.20% | -41.6% |
Sell | ATERIAN INCput | $1,404,000 | -49.9% | 1,296 | -32.3% | 0.19% | -51.9% | |
Sell | TRILLIUM THERAPEUTICS INC | $1,229,000 | -11.7% | 70,000 | -51.2% | 0.17% | -15.3% | |
ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $1,225,000 | -51.5% | 688,400 | -10.0% | 0.17% | -53.4% |
NUZE | Sell | NUZEE INC | $1,098,000 | -47.2% | 499,047 | -24.4% | 0.15% | -49.5% |
Sell | CBAK ENERGY TECH INCput | $920,000 | -82.4% | 3,521 | -68.2% | 0.12% | -83.2% | |
MRTX | Sell | MIRATI THERAPEUTICS INC | $885,000 | -8.7% | 5,000 | -16.7% | 0.12% | -12.4% |
Sell | NEMAURA MEDICAL INCput | $792,000 | -61.8% | 1,318 | -34.3% | 0.11% | -63.5% | |
Sell | CALADRIUS BIOSCIENCES INCput | $776,000 | -53.7% | 6,362 | -38.9% | 0.10% | -55.5% | |
AMRN | Sell | AMARIN CORP PLCadr | $759,000 | -47.0% | 148,771 | -54.5% | 0.10% | -49.0% |
Sell | OCEAN POWER TECHSput | $703,000 | -53.0% | 3,029 | -27.5% | 0.10% | -55.0% | |
LEXXW | Sell | LEXARIA BIOSCIENCE CORP.*w | $699,000 | -30.6% | 332,971 | -17.0% | 0.09% | -33.8% |
DXR | Sell | DAXOR CORP | $677,000 | -34.5% | 57,924 | -40.6% | 0.09% | -37.0% |
Sell | ARCADIA BIOSCIENCES INCput | $684,000 | -72.4% | 3,304 | -60.4% | 0.09% | -73.6% | |
ENOB | Sell | ENOCHIAN BIOSCIENCES INC | $534,000 | -92.0% | 79,314 | -94.1% | 0.07% | -92.3% |
KMPH | Sell | KEMPHARM INC | $387,000 | -82.5% | 41,531 | -75.9% | 0.05% | -83.3% |
Sell | GLOBUS MARITIME LTDput | $368,000 | -32.2% | 1,259 | -10.0% | 0.05% | -35.1% | |
Sell | ADITXT INCput | $361,000 | -74.3% | 2,135 | -60.6% | 0.05% | -75.3% | |
PRFX | Sell | PAINREFORM LTD | $326,000 | -66.7% | 117,528 | -66.2% | 0.04% | -68.1% |
SBEVWS | Sell | SPLASH BEVERAGE GROUP INC*w | $321,000 | -66.1% | 605,659 | -29.6% | 0.04% | -67.9% |
Sell | THE9 LTDcall | $297,000 | -50.7% | 288 | -31.8% | 0.04% | -52.9% | |
Sell | PHIO PHARMACEUTICALS CORPput | $281,000 | -23.2% | 1,383 | -14.7% | 0.04% | -26.9% | |
INFI | Sell | INFINITY PHARMACEUTICALS | $241,000 | -81.7% | 70,431 | -84.0% | 0.03% | -82.3% |
ADOM | Sell | ADOMANI INC | $232,000 | -87.3% | 850,000 | -86.2% | 0.03% | -87.9% |
Sell | TRILLIUM THERAPEUTICS INCcall | $211,000 | +80.3% | 120 | -0.8% | 0.03% | +81.2% | |
ADTX | Sell | ADITXT INC | $208,000 | -56.7% | 122,863 | -33.7% | 0.03% | -58.8% |
ATHX | Sell | ATHERSYS INC NEW | $155,000 | -68.8% | 116,444 | -66.3% | 0.02% | -70.0% |
Sell | REWALK ROBOTICS LTDput | $127,000 | -81.2% | 839 | -79.0% | 0.02% | -82.1% | |
Sell | DIGINEX LTDput | $119,000 | -62.8% | 367 | -24.8% | 0.02% | -64.4% | |
Sell | NABRIVA THERAPEUTICS PLCput | $94,000 | -43.0% | 790 | -35.5% | 0.01% | -43.5% | |
HCDIW | Sell | HARBOR CUSTOM DEVELOPMENT INC*w | $83,000 | -51.5% | 148,975 | -45.3% | 0.01% | -54.2% |
PHIO | Sell | PHIO PHARMACEUTICALS CORP | $83,000 | -29.1% | 40,684 | -21.4% | 0.01% | -31.2% |
Sell | PURPLE BIOTECH LTDput | $57,000 | -94.3% | 125 | -93.9% | 0.01% | -94.4% | |
Sell | EVOFEM BIOSCIENCES INCVput | $54,000 | -49.5% | 725 | -23.3% | 0.01% | -53.3% | |
CBAT | Sell | CBAK ENERGY TECH INC | $41,000 | -95.0% | 17,548 | -90.0% | 0.01% | -94.8% |
Sell | NABRIVA THERAPEUTICS PLC | $44,000 | -43.6% | 36,735 | -36.4% | 0.01% | -45.5% | |
Sell | TITAN PHARMACEUTICALS INCput | $34,000 | -89.7% | 184 | -85.6% | 0.01% | -89.4% | |
Sell | TANZANIAN GOLD CORPput | $20,000 | -75.0% | 404 | -74.2% | 0.00% | -72.7% | |
Sell | IT TECH PACKAGINGput | $17,000 | -70.7% | 254 | -79.3% | 0.00% | -75.0% | |
ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -14,979 | -100.0% | -0.01% | – |
TCDA | Exit | TRICIDA INCcall | $0 | – | -146 | -100.0% | -0.01% | – |
Exit | ADAMIS PHARMACEUTICALS CORPcall | $0 | – | -553 | -100.0% | -0.01% | – | |
Exit | AETERNA ZENTARIS INCput | $0 | – | -920 | -100.0% | -0.01% | – | |
LIXTW | Exit | LIXTE BIOTECHNOLOGY INC*w | $0 | – | -140,089 | -100.0% | -0.02% | – |
Exit | VASCULAR BIOGENICS LTDput | $0 | – | -492 | -100.0% | -0.02% | – | |
Exit | REDHILL BIOPHARMA LTDcall | $0 | – | -170 | -100.0% | -0.02% | – | |
Exit | META MATERIALS INCput | $0 | – | -182 | -100.0% | -0.02% | – | |
TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -10,042 | -100.0% | -0.02% | – |
Exit | HEPION PHARMS INCput | $0 | – | -980 | -100.0% | -0.03% | – | |
LIXT | Exit | LIXTE BIOTECHNOLOGY INC | $0 | – | -65,511 | -100.0% | -0.03% | – |
AEZS | Exit | AETERNA ZENTARIS INC | $0 | – | -244,240 | -100.0% | -0.03% | – |
Exit | HEPION PHARMS INCcall | $0 | – | -1,110 | -100.0% | -0.03% | – | |
Exit | MACROGENICS INCcall | $0 | – | -92 | -100.0% | -0.04% | – | |
PPBT | Exit | PURPLE BIOTECH LTDads | $0 | – | -50,590 | -100.0% | -0.04% | – |
SLRX | Exit | SALARIUS PHARMACEUTICALS | $0 | – | -249,033 | -100.0% | -0.04% | – |
BIOC | Exit | BIOCEPT INC | $0 | – | -76,892 | -100.0% | -0.04% | – |
GOEDWS | Exit | 1847 GOEDEKER INC*w | $0 | – | -180,000 | -100.0% | -0.05% | – |
JOB | Exit | GEE GROUP INC | $0 | – | -700,000 | -100.0% | -0.06% | – |
Exit | MACROGENICS INCput | $0 | – | -182 | -100.0% | -0.07% | – | |
Exit | BIOCEPT INCput | $0 | – | -1,160 | -100.0% | -0.07% | – | |
CLRB | Exit | CELLECTAR BIOSCIENCES | $0 | – | -426,561 | -100.0% | -0.07% | – |
Exit | ADAMIS PHARMACEUTICALS CORPput | $0 | – | -5,168 | -100.0% | -0.08% | – | |
Exit | APPLIED GENETIC TECHNOLOGIESput | $0 | – | -1,545 | -100.0% | -0.08% | – | |
METX | Exit | METEN EDTECHX EDUCATION LTDord | $0 | – | -733,840 | -100.0% | -0.10% | – |
SHIP | Exit | SEANERGY MARITIME HLDGS CORP | $0 | – | -650,000 | -100.0% | -0.10% | – |
TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -625,000 | -100.0% | -0.10% | – |
BCTX | Exit | BRIACELL THERAPEUTICS | $0 | – | -196,033 | -100.0% | -0.15% | – |
CVM | Exit | CEL-SCI CORP | $0 | – | -145,285 | -100.0% | -0.18% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -4,000 | -100.0% | -0.20% | – |
Exit | CEL-SCI CORPput | $0 | – | -1,916 | -100.0% | -0.23% | – | |
Exit | ASENSUS SURGICAL INCput | $0 | – | -5,594 | -100.0% | -0.25% | – | |
CBLI | Exit | CLEVELAND BIOLABS INC | $0 | – | -400,080 | -100.0% | -0.31% | – |
Exit | KEMPHARM INCcall | $0 | – | -1,735 | -100.0% | -0.31% | – | |
Exit | BIT BROTHER LTD | $0 | – | -1,039,458 | -100.0% | -0.32% | – | |
RDHL | Exit | REDHILL BIOPHARMA LTDads | $0 | – | -340,440 | -100.0% | -0.33% | – |
ASXC | Exit | ASENSUS SURGICAL INC | $0 | – | -931,414 | -100.0% | -0.42% | – |
ATER | Exit | ATERIAN INC. | $0 | – | -433,000 | -100.0% | -0.89% | – |
ATOS | Exit | ATOSSA THERAPEUTICS INC | $0 | – | -1,045,987 | -100.0% | -0.93% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.